Victoria Song

Science Corporation (what a name!) announced preliminary clinical trial results of their Prima retinal implant. Wired’s write-up goes into more detail, but the 2mm chip acts as a replacement photoreceptor in the retinas of folks who lost their central vision. After a year, some trial participants were able to read, solve crossword puzzles, and play cards. It’s not the same as normal vision — there’s no color, for instance. But it’s impressive nonetheless!

The New York Times just ran a story diving into how AnPhu Nguyen and Caine Ardayfio turned Ray-Ban Meta Smart Glasses to identify people in real-time earlier this month. As the headline states — it wasn’t hard, and that’s the chilling part.

Peloton announces its Q1 2025 earnings next Thursday, meaning it’s about time when they announce some good news to jazz up investors. This time around, it’s a holiday partnership with Costco starting November 1st to sell its Bike Plus for a slightly discounted $1,999 (in-store) or $2,199 (online, with delivery). We’ll see how investors feel about it next week.

Google’s been absorbing Fitbit at a steady rate over the 18 months or so and now, it’s also retiring the OG Fitbit Twitter — er, X — account. It’s not at all surprising, but something about this really underscores that Fitbit is Google now.